bpc 157 human clinical trial dose microgram BPC-157 Micro-Dosing: Is Less More for Chronic Conditions? BPC-157 Peptide | BPC-157 Synthetic
Description
Juvenile myasthenia gravis with prepubertal onset
Drug Design, Development and Therapy, 9, 2485-2499
[DOI] [PubMed] [Google Scholar] 70.Zemba Cilic A., Zemba M., Cilic M., Balenovic I., Strbe S., Ilic S., Vukojevic J., Zoricic Z., Filipcic I., Kokot A., et al
, , , BPC 157()
